NCT06834373
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06834373
Title Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona RECRUITING Scottsdale Arizona 85259 United States Details
Mayo Clinic in Florida RECRUITING Jacksonville Florida 32224-9980 United States Details
Mayo Clinic Health System in Albert Lea RECRUITING Albert Lea Minnesota 56007 United States Details
Mayo Clinic Health Systems-Mankato RECRUITING Mankato Minnesota 56001 United States Details
Mayo Clinic in Rochester RECRUITING Rochester Minnesota 55905 United States Details
Mayo Clinic Health System-Eau Claire Clinic RECRUITING Eau Claire Wisconsin 54701 United States Details
Mayo Clinic Health System-Franciscan Healthcare RECRUITING La Crosse Wisconsin 54601 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field